Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 6, 2009, Pages 767-773

  Stahl, Andreas ^a   Paschek, Lilija ^a   Martin, Gottfried ^a   Feltgen, Nicolas ^a   Hansen, Lutz L ^a   Agostini, Hansjürgen T ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

AMD; Angiogenesis; Bevacizumab; CNV; Endothelial; Retina; RPE; Spheroid

Indexed keywords

BEVACIZUMAB; COLLAGEN; CYTOKERATIN 18; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR ANTIBODY; MESSENGER RNA; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ARTICLE; CELL ISOLATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOTHERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; SUBRETINAL NEOVASCULARIZATION;

ACTINS; ANGIOGENESIS INHIBITORS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CHOROIDAL NEOVASCULARIZATION; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; KERATIN-18; NERVE GROWTH FACTORS; POLYMERASE CHAIN REACTION; RETINAL PIGMENT EPITHELIUM; RNA, MESSENGER; SERPINS; SPHEROIDS, CELLULAR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67349267785     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1058-x     Document Type: Article

References (40)

1. Ferrara N, Damico L, Shams N, Lowman H, Kim R (2006) Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26:859-870. doi: 10.1097/01.iae.0000242842.14624.e7
2. Miller H, Miller B, Ryan SJ (1986) The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci 27:1644-1652
3. Sakamoto T, Sakamoto H, Hinton DR, Spee C, Ishibashi T, Ryan SJ (1995) In vitro studies of human choroidal endothelial cells. Curr Eye Res 14:621-627. doi: 10.3109/02713689508998488
4. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP (2000) Oxidative damage and protection of the RPE. Prog Retin Eye Res 19:205-221. doi: 10.1016/ S1350-9462(99)00009-9
5. Ng EW, Adamis AP (2005) Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol 40:352-368
6. Ni M, Holland M, Jarstadmarken H, De Vries G (2005) Time-course of experimental choroidal neovascularization in Dutch-Belted rabbit: clinical and histological evaluation. Exp Eye Res 81:286-297
7. Gibran SK, Sachdev A, Stappler T, Newsome R, Wong D, Hiscott P (2007) Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin). Br J Ophthalmol 91:602-604. doi: 10.1136/bjo.2006.108795
8. Casaroli-Marano RP, Pagan R, Vilaro S (1999) Epithelial-mesenchymal transition in proliferative vitreoretinopathy: Intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 40:2062-2072
9. Grisanti S, Guidry C (1995) Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci 36:391-405
10. Schlunck G, Martin G, Agostini HT, Camatta G, Hansen LL (2002) Cultivation of retinal pigment epithelial cells from human choroidal neovascular membranes in age related macular degeneration. Exp Eye Res 74:571-576. doi: 10.1006/exer.2001.1148
11. Stahl A, Paschek L, Martin G, Gross NJ, Feltgen N, Hansen LL, Agostini HT (2008) Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro. FEBS Lett 582:3097-3102. doi: 10.1016/j.febslet.2008.08.005
12. Korff T, Augustin HG (1998) Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol 143:1341-1352. doi: 10.1083/jcb.143.5.1341
13. Korff T, Augustin HG (1999) Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J Cell Sci 112(Pt 19):3249-3258
14. Wenger A, Stahl A, Weber H, Finkenzeller G, Augustin HG, Stark GB, Kneser U (2004) Modulation of in vitro angiogenesis in a three-dimensional spheroidal coculture model for bone tissue engineering. Tissue Eng 10:1536-1547
15. Kliffen M, Sharma HS, Mooy CM, Kerkvliet S, de Jong PT (1997) Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 81:154-162. doi: 10.1136/bjo.81.2.154
16. Otani A, Takagi H, Oh H, Koyama S, Matsumura M, Honda Y (1999) Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes. Invest Ophthalmol Vis Sci 40:1912-1920
17. Blaauwgeers HG, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, Alitalo K, Kroon ME, Kijlstra A, van Hinsbergh VW, Schlingemann RO (1999) Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol 155:421-428
18. Ishigooka H, Aotaki-Keen AE, Hjelmeland LM (1992) Subcellular localization of bFGF in human retinal pigment epithelium in vitro. Exp Eye Res 55:203-214. doi: 10.1016/0014-4835(92)90184-T
19. Amin R, Puklin JE, Frank RN (1994) Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci 35:3178-3188
20. Reddy VM, Zamora RL, Kaplan HJ (1995) Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. Am J Ophthalmol 120:291-301
21. Martin G, Schlunck G, Hansen LL, Agostini HT (2004) Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 242:321-326. doi: 10.1007/s00417-003-0838-y
22. Chen CY, Wong TY, Heriot WJ (2007) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: A short-term study. Am J Ophthalmol 143:510-512. doi: 10.1016/j.ajo.2006.10.004
23. Giansanti F, Virgili G, Bini A, Rapizzi E, Giacomelli G, Donati MC, Verdina T, Menchini U (2007) Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study. Eur J Ophthalmol 17:230-237
24. Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML (2007) Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration. Retina 27:439-444. doi: 10.1097/IAE.0b013e31804b3e15
25. McLeod DS, Taomoto M, Otsuji T, Green WR, Sunness JS, Lutty GA (2002) Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci 43:1986-1993
26. Rosenthal R, Strauss O (2003) Investigations of RPE cells of choriodal neovascular membranes from patients with age-related macula degeneration. Adv Exp Med Biol 533:107-113
27. Rosenthal R, Heimann H, Agostini H, Martin G, Hansen LL, Strauss O (2007) Ca2+ channels in retinal pigment epithelial cells regulate vascular endothelial growth factor secretion rates in health and disease. Mol Vis 13:443-456
28. Hunt RC, Davis AA (1990) Altered expression of keratin and vimentin in human retinal pigment epithelial cells in vivo and in vitro. J Cell Physiol 145:187-199. doi: 10.1002/jcp.1041450202
29. Stahl A, Wu X, Wenger A, Klagsbrun M, Kurschat P (2005) Endothelial progenitor cell sprouting in spheroid cultures is resistant to inhibition by osteoblasts: A model for bone replacement grafts. FEBS Lett 579:5338-5342. doi: 10.1016/j.febslet.2005.09.005
30. Korff T, Kimmina S, Martiny-Baron G, Augustin HG (2001) Blood vessel maturation in a 3-dimensional spheroidal coculture model: Direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J 15:447-457. doi: 10.1096/ fj.00-0139com
31. Takeda Y, Kazarov AR, Butterfield CE, Hopkins BD, Benjamin LE, Kaipainen A, Hemler ME (2007) Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 109:1524-1532. doi: 10.1182/blood-2006-08-041970
32. Geisen P, McColm JR, Hartnett ME (2006) Choroidal endothelial cells transmigrate across the retinal pigment epithelium but do not proliferate in response to soluble vascular endothelial growth factor. Exp Eye Res 82:608-619. doi: 10.1016/j.exer.2005.08.021
33. Dorrell MI, Aguilar E, Scheppke L, Barnett FH, Friedlander M (2007) Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis. Proc Natl Acad Sci USA 104:967-972. doi: 10.1073/ pnas.0607542104
34. Castellon R, Hamdi HK, Sacerio I, Aoki AM, Kenney MC, Ljubimov AV (2002) Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp Eye Res 74:523-535. doi: 10.1006/exer.2001.1161
35. Relf M, LeJeune S, Scott PA, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R, Harris AL (1997) Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57:963-969
36. Spaide RF (2006) Rationale for combination therapies for choroidal neovascularization. Am J Ophthalmol 141:149-156. doi: 10.1016/ j.ajo.2005.07.025
37. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD (1995) Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 92:11-14
38. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P (1998) Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis. J Cell Biol 141:1659-1673. doi: 10.1083/jcb.141.7.1659
39. Zubilewicz A, Hecquet C, Jeanny JC, Soubrane G, Courtois Y, Mascarelli F (2001) Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: A comparative study with VEGF. Oncogene 20:1403-1413. doi: 10.1038/sj.onc.1204231
40. Im E, Kazlauskas A (2006) Regulating angiogenesis at the level of PtdIns-4,5-P2. EMBO J 25:2075-2082. doi: 10.1038/sj.emboj.7601100